Here in Norway we have this deal where oil companies can get refunded a significant fraction of their expenses searching for oil if they didn't make a profit[1]

Here in Norway we have this deal where oil companies can get refunded a significant fraction of their expenses searching for oil if they didn't make a profit[1]. On the flip side, once they start making a profit, they have to pay a similarly high fraction in taxes. This is to incentivize searching while also letting the profits benefit the majority. Had a shower thought if such a model might have worked on the pharmaceutical market as well. [1]: https://www.nrk.no/klima/xl/leterefusjonen_-disse-selskapene-har-lett-etter-olje-for-dine-skattepenger-1.15931075 https://www.nrk.no/klima/xl/leterefusjonen_-disse-selskapene...